M42 delivers comprehensive healthcare services across the full continuum of care; from primary care to advanced specialty treatments. Leveraging cutting‑edge health technologies and precision medicine, we ensure the highest standards of effectiveness, efficiency, and patient‑centered outcomes. With a global presence spanning more than 480 facilities in 27 countries and a dedicated workforce of over 20,000 professionals, M42 is uniquely positioned to redefine the future of healthcare on a global scale.

Imperial College London Diabetes & Endocrine Centre (ICLDEC) is a global leader in diabetes and endocrine treatment, education and research. Established in 2006 by Mubadala in partnership with Restricted the UK’s Imperial College London, the Centre specializes in treating all types of diabetes and endocrine disorders, as well as focusing on diabetes research, training, and public health awareness. The Centre, which operates four branches across Abu Dhabi, Al Ain ...